Development Level

Tbio 3 | 10,625

Disease

Anemia 3 | 252
Beta thalassemia 3 | 19
Hemochromatosis 3 | 55
Thalassemia 3 | 46
medulloblastoma, large-cell 3 | 6,234
Aceruloplasminemia 2 | 17
Atransferrinemia 2 | 8
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Hereditary hemochromatosis 2 | 4
Kidney disease 2 | 396
Liver disease 2 | 219
Malaria 2 | 140
Nutritional deficiency disease 2 | 9
Obesity 2 | 616
Peripheral vascular disease 2 | 90
atypical teratoid / rhabdoid tumor 2 | 4,369
glioblastoma 2 | 5,572
ovarian cancer 2 | 8,484
Alzheimer's disease 1 | 644
Arenaviridae Infections 1 | 1
Biliary atresia 1 | 8
Bladder Neoplasm 1 | 109
Chronic Lymphocytic Leukemia 1 | 242
Colorectal Neoplasms 1 | 217
Combined immunodeficiency 1 | 2
Duchenne muscular dystrophy 1 | 602
Fatty liver disease 1 | 84
Finding of Mean Corpuscular Hemoglobin 1 | 14
Glioma 1 | 65
HEMOCHROMATOSIS, TYPE 2B 1 | 1
HEMOCHROMATOSIS, TYPE 3 1 | 1
Helicobacter Infections 1 | 5
Hematocrit level 1 | 6
Hemolytic anemia 1 | 66
Hepatitis C 1 | 90
Hepatolenticular Degeneration 1 | 24
Human immunodeficiency virus infectious disease 1 | 92
Hypersensitivity reaction type II disease 1 | 235
Inflammation 1 | 109
Iron Metabolism Disorders 1 | 5
Iron Overload 1 | 5
Iron deficiency anemia 1 | 6
Iron metabolism disease 1 | 17
Juvenile hemochromatosis 1 | 2
Kidney Failure, Chronic 1 | 45
Lung Neoplasms 1 | 171
Lymphoma, Non-Hodgkin 1 | 22
Mammary Neoplasms 1 | 410
Multiple myeloma 1 | 1,327
Myocardial Ischemia 1 | 169
Myocardial Reperfusion Injury 1 | 34
Neoplastic Cell Transformation 1 | 81
Neurodegenerative disease 1 | 383
Pick disease 1 | 1,893
Polycystic Ovary Syndrome 1 | 332
Porphyria cutanea tarda 1 | 12
Severe Combined Immunodeficiency 1 | 46
Siderosis 1 | 9
Spontaneous abortion 1 | 108
Waldenstrons macroglobulinemia 1 | 765
acute quadriplegic myopathy 1 | 1,157
astrocytic glioma 1 | 2,241
atypical teratoid/rhabdoid tumor 1 | 1,095
colon cancer 1 | 1,475
cystic fibrosis 1 | 1,665
ductal carcinoma in situ 1 | 1,745
esophageal adenocarcinoma 1 | 737
gastric carcinoma 1 | 832
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
nasopharyngeal carcinoma 1 | 1,056
non diabetic and post-ischemic heart failure 1 | 200
non-small cell lung cancer 1 | 2,798
osteosarcoma 1 | 7,933
pancreatic cancer 1 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primitive neuroectodermal tumor 1 | 3,031
progressive supranuclear palsy 1 | 674
psoriasis 1 | 6,685
type II diabetes mellitus and post-ischemic heart failure 1 | 89
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146

Grant Application

1R01DK063016-01A2 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Transferrin receptor protein 2 TFR2 Tbio Enzyme -2.09528 130.1 127
Hepcidin HAMP Tbio Non-IDG -3.23906 2012.9 263